Clinical TrialsSearch results
Number of results: 209
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- A phase 1 study of self-amplifying mRNA vaccine VLPCOV-01
Randomized, placebo-controlled, parallel group, first-in-human study (FIH Study)(COVID-19)
- Prevention of infectious disease caused by SARS-CoV-2
- Sato Nobuaki
- 2021-09-28
Recruiting
- Phase 2 clinical trial evaluating the efficacy and safety of ART-648 in patients with bullous pemphigoid
- Mild to moderate bullous pemphigoid
- Nagabukuro Hiroshi
- 2021-06-17
Completed
- Phase 2 clinical trial evaluating the efficacy and safety of ART-001 in patients with slow-flow vascular malformations
- Slow flow vascular malformations
- Nagabukuro Hiroshi
- 2021-05-25
Completed
- A Phase 3 Study of KW-0761 (Mogamulizumab) in Subjects with HTLV-1 Associated Myelopathy (HAM)
- HTLV-1 associated Myelopathy (HAM)
- Kyowa Kirin Co., Ltd
- 2018-01-23
Completed
- A Phase 3 Study of KW-0761 (Mogamulizumab) in Subjects with HTLV-1 Associated Myelopathy (HAM)
- HTLV-1 associated Myelopathy (HAM)
- Kyowa Kirin Co., Ltd
- 2018-01-23
Completed
- A Phase 3 Study of KW-0761 (Mogamulizumab) in Subjects with HTLV-1 Associated Myelopathy (HAM)
- HTLV-1 associated Myelopathy (HAM)
- Kyowa Kirin Co., Ltd
- 2018-01-23
Completed
- A Phase 3 Study of KW-0761 (Mogamulizumab) in Subjects with HTLV-1 Associated Myelopathy (HAM)
- HTLV-1 associated Myelopathy (HAM)
- Kyowa Kirin Co., Ltd
- 2018-01-23
Completed
- Multicenter trial of SPP-004 in mitochondrial diseases
- Mitochondrial disease, mainly to cranial nerve symptoms
- Saitama Medical University Hospital
- 2014-12-09
Completed
- Multicenter trial of SPP-004 in mitochondrial diseases
- Mitochondrial disease, mainly to cranial nerve symptoms
- Saitama Medical University Hospital
- 2014-12-09
Completed
- Multicenter trial of SPP-004 in mitochondrial diseases
- Mitochondrial disease, mainly to cranial nerve symptoms
- Saitama Medical University Hospital
- 2014-12-09